This firm has 20.37
B in debt with debt to equity (D/E) ratio of 0.51, which is OK given its current industry classification.
Medtronic PLC has a
performance score of 5 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.7055, which conveys possible diversification benefits within a given portfolio. Let's try to break down what Medtronic's beta means in this case. As returns on the market increase, Medtronic PLC returns are expected to increase less than the market. However, during the bear market, the loss on holding Medtronic PLC will be expected to be smaller as well. Although it is important to respect
Medtronic PLC price patterns, it is better to be realistic regarding the information on the equity's historical
price patterns. The philosophy towards estimating
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. By analyzing
Medtronic PLC technical indicators, you can presently evaluate if the expected return of 0.0973% will be sustainable into the future.
Medtronic PLC right now secures a risk of 1.39%. Please verify Medtronic PLC
variance, as well as the
relationship between the value at risk and
skewness to decide if Medtronic PLC will be following its current price movements.
We determine the current worth of Medtronic PLC using both absolute as well as relative valuation methodologies to arrive at its intrinsic value. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Medtronic PLC based exclusively on its
fundamental and basic
technical indicators. By analyzing Medtronic PLC's
financials, quarterly and monthly indicators, and related drivers such as
dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of
Medtronic PLC's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medtronic PLC. We calculate exposure to Medtronic PLC's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Medtronic PLC's related companies.
Medtronic PLC Investment Alerts
Medtronic investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring Medtronic PLC performance across your portfolios.Please check all
investment alerts for Medtronic
Medtronic PLC Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare Medtronic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medtronic PLC competition to find
correlations between indicators driving the intrinsic value of Medtronic.
Medtronic PLC Gross Profit
Medtronic PLC Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Medtronic PLC previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Medtronic PLC Gross Profit growth over the last 10 years. Please check Medtronic PLC's
gross profit and other
fundamental indicators for more details.
Is Medtronic PLC valued wisely by the market?
The newest indifference towards the small price fluctuations of Medtronic PLC may encourage private investors to take a closer look at the firm as it is trading at a share price of
87.49 on
6,786,073 in trading volume. The company management teams did not add any value to Medtronic PLC investors in
April. However, most investors can still diversify their portfolios with Medtronic PLC to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 1.39. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.
| 2015 | 2020 | 2023 (projected) |
Book Value per Share | 37.84 | 39.15 | 40.36 | Asset Turnover | 0.32 | 0.35 | 0.31 |
Margins Breakdown
Medtronic profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or Medtronic PLC itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of Medtronic PLC profit margins.
| EBITDA Margin | 0.25 |
| Gross Margin | 0.64 |
| Profit Margin | 0.15 |
Medtronic PLC Earnings before Tax is increasing over the last 5 years. Further, Medtronic PLC Earnings Before Interest Taxes and Depreciation Amortization USD is increasing over the last 5 years. The newest value of Medtronic PLC Earnings Before Interest Taxes and Depreciation Amortization USD is 8,258,605,263. Medtronic PLC Earnings before Tax is increasing over the last 5 years. The newest value of Medtronic PLC Earnings before Tax is 4,622,368,421. Further, Medtronic PLC Earnings Before Interest Taxes and Depreciation Amortization USD is comparatively stable at the moment.
Medtronic may start a correction in June
Coefficient of variation is down to 2392.58. It may call for a possible volatility drop.
Medtronic PLC has relatively low volatility with skewness of 0.79 and kurtosis of 1.62. However, we advise all investors to independently investigate Medtronic PLC to ensure
all accessible information is consistent with the expectations about its upside potential and future expected returns. Understanding different
market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Medtronic PLC's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact
Medtronic PLC's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
The Current Takeaway on Medtronic PLC Investment
Whereas many of the other players under the medical devices industry are still a bit expensive, Medtronic PLC may offer a potential longer-term growth to private investors. On the whole, as of the 25th of May 2023, we believe that Medtronic PLC is currently
undervalued with
very small odds of financial turmoil in the next two years. Our primary 90 days buy-hold-sell advice on the firm is
Strong Buy.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Ellen Johnson is a Member of Macroaxis Editorial Board. Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Ellen Johnson do not own shares of Medtronic PLC. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com